OnKure Therapeutics, Inc. (OKUR)

OnKure Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022
Period Ending	Nov 20, 2024	Dec 31, 2023	Dec 31, 2022
Debt / Equity Ratio	-1.25	0.02	0.06
Quick Ratio	0.43	4.10	2.08
Current Ratio	0.65	4.64	2.46
Return on Equity (ROE)	-	-186.07%	-
Return on Assets (ROA)	-	-89.24%	-
Return on Capital (ROIC)	-	-117.58%	-

Source: S&P Capital IQ. Standard template. Financial Sources.